Simplex Trading
DNA icon

Simplex Trading’s Ginkgo Bioworks DNA Stock Holding History

Simplex Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.5K Buy
+11,500
New +$95.7K ﹤0.01% 5487
2025
Q4 		– Sell
-87,700
Closed -$1.28M – 8879
2025
Q3 		$1.28M Buy
87,700
+13,100
+18% +$157K ﹤0.01% 2793
2025
Q2 		$839K Sell
74,600
-28,500
-28% -$221K ﹤0.01% 2956
2025
Q1 		$587K Sell
103,100
-49,600
-32% -$505K ﹤0.01% 3226
2024
Q4 		$1.5M Buy
152,700
+1,500
+1% +$12.9K ﹤0.01% 2457
2024
Q3 		$1.23M Buy
151,200
+142,485
+1,635% +$1.43M ﹤0.01% 2718
2024
Q2 		$116K Sell
8,715
-4,405
-34% -$131K ﹤0.01% 5224
2024
Q1 		$608K Sell
13,120
-1,848
-12% -$95.7K ﹤0.01% 3648
2023
Q4 		$1.01M Buy
14,968
+2,695
+22% +$165K ﹤0.01% 2990
2023
Q3 		$888K Sell
12,273
-2,902
-19% -$232K ﹤0.01% 2793
2023
Q2 		$1.13M Buy
15,175
+4,100
+37% +$243K ﹤0.01% 2489
2023
Q1 		$589K Buy
11,075
+5,535
+100% +$351K ﹤0.01% 3101
2022
Q4 		$374K Sell
5,540
-9,833
-64% -$904K ﹤0.01% 3493
2022
Q3 		$1.92M Buy
15,373
+11,193
+268% +$1.33M ﹤0.01% 1993
2022
Q2 		$397K Sell
4,180
-2,785
-40% -$340K ﹤0.01% 3736
2022
Q1 		$1.12M Buy
6,965
+167
+2% +$32.5K ﹤0.01% 2776
2021
Q4 		$2.26M Buy
+6,798
New +$3.23M ﹤0.01% 1908

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's DNA Position: Q1 2026 in Review

Simplex Trading opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 7,474 shares worth $45.8K. The stake represents ﹤0.01% of the portfolio and ranks #5969 among its holdings. This is a return to the name: Simplex Trading previously reported a position in DNA as recently as Q3 2025.

Simplex Trading first reported a position in DNA in Q1 2022 and has held it in 14 quarters since. The position peaked at $990K in Q1 2022. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Simplex Trading held 7,474 shares of Ginkgo Bioworks worth $45.8K as of Q1 2026.
  • Ginkgo Bioworks was a new Simplex Trading position in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5969 holding.
  • Simplex Trading first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 14 quarters since.
  • Simplex Trading's Ginkgo Bioworks position peaked at $990K in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.